A phase III trial (RTOG 0129) of two radiation-cisplatin regimens for head and neck carcinomas (HNC): Impact of radiation and cisplatin intensity on outcome.

被引：30

作者：

Ang, K.

Zhang, Q.

Wheeler, R. H.

Rosenthal, D. I.

Nguyen-Tan, F.

Kim, H.

Lu, C.

Axelrod, R. S.

Silverman, C. I.

Weber, R. S.

机构：

[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[2] RTOG Stat Ctr, Philadelphia, PA USA

[3] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA

[4] Ctr Hosp Univ Montreal, Montreal, PQ, Canada

[5] Wayne State Univ, Karmanos Canc Inst, Detroit, MI USA

[6] Thomas Jefferson Univ, Philadelphia, PA 19107 USA

[7] Univ Louisville, Louisville, KY 40292 USA

来源：

关键词：

D O I：

10.1200/jco.2010.28.15_suppl.5507

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

5507

引用

页数：2